Description

How This Works

CJC-1295 DAC mimics endogenous GHRH, binding to GHRH receptors on pituitary somatotrophs to drive GH release^[2]. The DAC modification (albumin-binding moiety) keeps the GHRH analog circulating for days rather than minutes, extending the half-life to approximately 6–8 days^[1]. The resulting GH surge stimulates IGF-1 production (primarily in the liver); IGF-1 then mediates many growth and metabolic effects through JAK/STAT signaling pathways^[4]. Notably, pulsatile GH secretion persists even during continuous CJC-1295 stimulation, preserving physiological release patterns^[2].

Potential Benefits & Side Effects

Observations from preclinical and clinical literature.

• Supports sustained elevation of GH and IGF-1 in a dose-dependent manner^[1].
• May promote increased lean body mass, reduced fat mass, and improved body composition consistent with GH/IGF-1 axis activation^[4][9].
• Enhanced protein synthesis and recovery potential through anabolic signaling^[4].
• Generally well tolerated in clinical studies; occasional mild injection-site reactions (redness, swelling) may occur^[1].
• Some individuals report transient flushing, headache, or water retention during initial titration.

Lifestyle Factors

Complementary strategies for best outcomes.

• Pair with a balanced, protein-forward diet tailored to energy and recovery needs.
• Combine resistance training and aerobic activity to reinforce GH-mediated adaptations.
• Prioritize quality sleep (7–9 hours) as endogenous GH release peaks during deep sleep^[4].
• Manage stress to support hormonal balance and adherence.